SG Americas Securities’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $927K | Sell |
80,040
-2,366
| -3% | -$27.4K | ﹤0.01% | 1104 |
|
|
2025
Q1 | $719K | Buy |
82,406
+9,360
| +13% | +$81.7K | ﹤0.01% | 1315 |
|
|
2024
Q4 | $1.05M | Buy |
73,046
+49,468
| +210% | +$710K | ﹤0.01% | 734 |
|
|
2024
Q3 | $532K | Sell |
23,578
-77,766
| -77% | -$1.75M | ﹤0.01% | 1444 |
|
|
2024
Q2 | $1.97M | Buy |
101,344
+86,967
| +605% | +$1.69M | 0.01% | 885 |
|
|
2024
Q1 | $540K | Buy |
+14,377
| New | +$540K | ﹤0.01% | 1245 |
|
|
2023
Q4 | – | Sell |
-64,162
| Closed | -$2.65M | – | 3074 |
|
|
2023
Q3 | $2.65M | Buy |
64,162
+43,070
| +204% | +$1.78M | 0.03% | 523 |
|
|
2023
Q2 | $1.18M | Buy |
21,092
+4,135
| +24% | +$231K | 0.01% | 881 |
|
|
2023
Q1 | $946K | Sell |
16,957
-11,600
| -41% | -$647K | 0.01% | 1069 |
|
|
2022
Q4 | $1.04M | Sell |
28,557
-2,943
| -9% | -$107K | 0.01% | 817 |
|
|
2022
Q3 | $897K | Sell |
31,500
-18,748
| -37% | -$534K | 0.01% | 940 |
|
|
2022
Q2 | $2.27M | Buy |
50,248
+47,047
| +1,470% | +$2.13M | 0.02% | 567 |
|
|
2022
Q1 | $244K | Buy |
+3,201
| New | +$244K | ﹤0.01% | 2062 |
|
|
2021
Q4 | – | Sell |
-26,116
| Closed | -$3.8M | – | 3361 |
|
|
2021
Q3 | $3.8M | Sell |
26,116
-3,019
| -10% | -$440K | 0.02% | 646 |
|
|
2021
Q2 | $5.71M | Buy |
29,135
+23,777
| +444% | +$4.66M | 0.03% | 490 |
|
|
2021
Q1 | $970K | Sell |
5,358
-23,873
| -82% | -$4.32M | 0.01% | 1417 |
|
|
2020
Q4 | $4.14M | Buy |
29,231
+27,561
| +1,650% | +$3.9M | 0.02% | 524 |
|
|
2020
Q3 | $208K | Buy |
1,670
+101
| +6% | +$12.6K | ﹤0.01% | 1788 |
|
|
2020
Q2 | $140K | Buy |
+1,569
| New | +$140K | ﹤0.01% | 2719 |
|
|
2019
Q4 | – | Sell |
-4,029
| Closed | -$203K | – | 2819 |
|
|
2019
Q3 | $203K | Buy |
+4,029
| New | +$203K | ﹤0.01% | 2009 |
|